CRANBURY, N.J.--(BUSINESS WIRE)--Jun. 28, 2024-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company...
Vous n'êtes pas connecté
Intra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight following pipeline and regulatory updates, respectively.
CRANBURY, N.J.--(BUSINESS WIRE)--Jun. 28, 2024-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company...
Intra-Cellular (ITCI) is witnessing strong Caplyta sales, driven by an increasing prescription rate. However, the company is heavily dependent on...
Cartesian (RNAC) announced that the phase IIb study in MG patients has achieved its primary endpoints. However, the stock nosedives following an...
FDA rejects Merck (MRK) and AbbVie's (ABBV) filings for pipeline candidates. AstraZeneca (AZN) and Novo Nordisk (NVO) announce study failures.
Latest business News, Live Updates Today: Get real-time updates on the biggest news from the world of business, stock market and more.
Latest business News, Live Updates Today: Get real-time updates on the biggest news from the world of business, stock market and more.
Latest business News, Live Updates Today: Get real-time updates on the biggest news from the world of business, stock market and more.
Latest business News, Live Updates Today: Get real-time updates on the biggest news from the world of business, stock market and more.
Latest business News, Live Updates Today: Get real-time updates on the biggest news from the world of business, stock market and more.
Mesoblast (MESO) skyrockets 208.2% year to date on encouraging progress with its pipeline candidates.